MENU
+Compare
MXCT
Stock ticker: NASDAQ
AS OF
Aug 15 closing price
Price
$1.36
Change
-$0.05 (-3.55%)
Capitalization
144.99M

MXCT MaxCyte Forecast, Technical & Fundamental Analysis

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development... Show more

MXCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MXCT with price predictions
Aug 15, 2025

MXCT sees MACD Histogram just turned negative

MXCT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 31, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MXCT as a result. In of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MXCT moved below its 50-day moving average on July 29, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MXCT advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

MXCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 107 cases where MXCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.760) is normal, around the industry mean (59.359). P/E Ratio (0.000) is within average values for comparable stocks, (38.307). MXCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.709). MXCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.023) is also within normal values, averaging (77.214).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MXCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
MXCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MXCT is expected to report earnings to fall 16.67% to -10 cents per share on November 05

MaxCyte MXCT Stock Earnings Reports
Q3'25
Est.
$-0.10
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 917.54K shares outstanding, the current market capitalization sits at 144.99M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
9713 Key West Avenue
Phone
+1 301 944-1700
Employees
143
Web
https://www.maxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTKFY17.720.35
+1.99%
PT Kalba Farma TBK
BXBLY30.130.19
+0.63%
Brambles, Ltd.
OLVI0.83N/A
+0.01%
Oliveda International, Inc.
CBAF28.50N/A
N/A
Citba Financial Corp.
OVTZ0.03N/A
-4.91%
OCULUS INC.

MXCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MXCT has been loosely correlated with HAE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MXCT jumps, then HAE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MXCT
1D Price
Change %
MXCT100%
-3.55%
HAE - MXCT
49%
Loosely correlated
+2.69%
A - MXCT
44%
Loosely correlated
+0.28%
RVTY - MXCT
43%
Loosely correlated
+1.49%
BLFS - MXCT
41%
Loosely correlated
-3.87%
QGEN - MXCT
41%
Loosely correlated
+0.80%
More

Groups containing MXCT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MXCT
1D Price
Change %
MXCT100%
-3.55%
Medical/Nursing Services
industry (227 stocks)
35%
Loosely correlated
-0.81%
Health Services
industry (441 stocks)
26%
Poorly correlated
-0.03%